Table 2.
Comparison of demographics of kidney transplant recipients between TRAS group and control group
| Items | TRAS (n = 12) | Control (n = 6) | Statistics | P |
|---|---|---|---|---|
| Gender (male/female) | 9/3 | 5/1 | Fisher | 1.000 |
| Age (years) | 33.5 (28.0, 37.5) | 38.5 (36.0, 40.0) | −1.315* | 0.188 |
| Height (cm) | 170.0 (164.5, 171.5) | 171.0 (168.0, 172.0) | −0.758* | 0.448 |
| Weight (kg) | 59.0 (51.0, 70.0) | 59.0 (53.0, 72.0) | −0.423* | 0.672 |
| Donor type (deceased/living–related) | 10/2 | 5/1 | Fisher | 1.000 |
| Time to CTA examination (months PT) | 4.0 (3.0, 6.5) | 8.5 (7.0, 13.0) | −1.977* | 0.048 |
| CNI (FK/CsA/none) | 9/3/0 | 4/1/1 | Fisher | 0.492 |
| MPA (MMF/EC–MPS/none) | 12/0/0 | 4/1/1 | Fisher | 0.098 |
*Z values. PT: Posttransplant; CNI: Calcineurin inhibitor; CTA: Computed tomography angiography; MPA: Mycophenolic acid; MMF: Mycophenolate mofetil; EC–MPS: Enteric–coated mycophenolate sodium; FK: FK506; CsA: Cyclosporine A; TRAS: Transplant renal artery stenosis.